Security key
36315X101
Lakefront Biotherapeutics NV - Ordinary shares, no par value (GLPG)
CUSIP: 36315X101
Q4 2015 13F Holders as of 31 Dec 2015
- Type / Class
- Equity / Ordinary shares, no par value
- Shares outstanding
- 66,186,595
- Total 13F shares
- 8,237,090
- Share change
- -811,021
- Total reported value
- $517,944,000
- Price per share
- $62.88
- Number of holders
- 43
- Value change
- -$28,678,609
- Number of buys
- 27
- Number of sells
- 20
Report period
Q4 2015
Institutions
43
Top holders
10
GLPG full security history
Newer quarter: Q1 2016
Previous quarter: Q3 2015
Lakefront Biotherapeutics NV SEC filings
Lakefront Biotherapeutics NV company facts
Broader feeds
Reporting periods
Holder history for CUSIP 36315X101
Recent filing periods:
Top shareholders of GLPG - Lakefront Biotherapeutics NV - Ordinary shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
5.9%
|
3,896,284
|
$158,618,000 | — | 30 Sep 2015 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
1.7%
|
1,101,730
|
$44,851,000 | — | 30 Sep 2015 | |
| GILDER GAGNON HOWE & CO LLC |
13F
|
Company |
0.89%
|
585,870
|
$23,851,000 | — | 30 Sep 2015 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.8%
|
526,460
|
$21,433,000 | — | 30 Sep 2015 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.77%
|
512,900
|
$20,880,000 | — | 30 Sep 2015 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
0.67%
|
441,085
|
$17,957,000 | — | 30 Sep 2015 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.56%
|
369,276
|
$15,033,000 | — | 30 Sep 2015 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.51%
|
337,083
|
$13,723,000 | — | 30 Sep 2015 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.5%
|
333,374
|
$13,572,000 | — | 30 Sep 2015 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.32%
|
210,000
|
$8,549,000 | — | 30 Sep 2015 | |
| Zweig-DiMenna Associates LLC |
13F
|
Company |
0.26%
|
171,840
|
$6,996,000 | — | 30 Sep 2015 | |
| RS INVESTMENT MANAGEMENT CO LLC |
13F
|
Company |
0.15%
|
97,182
|
$3,956,000 | — | 30 Sep 2015 | |
| MORGAN STANLEY |
13F
|
Company |
0.12%
|
81,621
|
$3,322,000 | — | 30 Sep 2015 | |
| Atika Capital Management LLC |
13F
|
Company |
0.1%
|
65,500
|
$2,666,000 | — | 30 Sep 2015 | |
| Graticule Asia Macro Advisors LLC |
13F
|
Company |
0.08%
|
50,000
|
$2,036,000 | — | 30 Sep 2015 | |
| OLD MISSION CAPITAL LLC |
13F
|
Company |
0.06%
|
42,473
|
$1,729,000 | — | 30 Sep 2015 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.06%
|
38,239
|
$1,556,000 | — | 30 Sep 2015 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.04%
|
25,984
|
$1,058,000 | — | 30 Sep 2015 | |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ |
13F
|
Company |
0.04%
|
25,192
|
$1,025,000 | — | 30 Sep 2015 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.04%
|
23,581
|
$960,000 | — | 30 Sep 2015 | |
| Weiss Multi-Strategy Advisers LLC |
13F
|
Company |
0.03%
|
20,500
|
$835,000 | — | 30 Sep 2015 | |
| Tekla Capital Management LLC |
13F
|
Company |
0.03%
|
20,000
|
$814,000 | — | 30 Sep 2015 | |
| Rail-Splitter Capital Management, LLC |
13F
|
Company |
0.02%
|
13,164
|
$536,000 | — | 30 Sep 2015 | |
| NAVELLIER & ASSOCIATES INC |
13F
|
Company |
0.02%
|
11,780
|
$480,000 | — | 30 Sep 2015 | |
| GLG Partners LP |
13F
|
Company |
0.02%
|
11,684
|
$476,000 | — | 30 Sep 2015 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.02%
|
10,000
|
$407,000 | — | 30 Sep 2015 | |
| NOMURA ASSET MANAGEMENT CO LTD |
13F
|
Company |
0.02%
|
10,000
|
$407,000 | — | 30 Sep 2015 | |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. |
13F
|
Company |
0.01%
|
6,000
|
$244,000 | — | 30 Sep 2015 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
3,410
|
$139,000 | — | 30 Sep 2015 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0%
|
1,709
|
$70,000 | — | 30 Sep 2015 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0%
|
1,500
|
$61,000 | — | 30 Sep 2015 | |
| Creative Planning |
13F
|
Company |
0%
|
1,300
|
$53,000 | — | 30 Sep 2015 | |
| Walleye Trading LLC |
13F
|
Company |
0%
|
500
|
$20,000 | — | 30 Sep 2015 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
420
|
$17,000 | — | 30 Sep 2015 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
219
|
$9,000 | — | 30 Sep 2015 | |
| Edge Wealth Management LLC |
13F
|
Company |
0%
|
200
|
$8,000 | — | 30 Sep 2015 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
19
|
$1,000 | — | 30 Sep 2015 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
2
|
$81 | — | 30 Sep 2015 |
Institutional Holders of Lakefront Biotherapeutics NV - Ordinary shares, no par value (GLPG) as of Q4 2015
As of 31 Dec 2015,
Lakefront Biotherapeutics NV - Ordinary shares, no par value (GLPG) was held by
43 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,237,090 shares.
The largest 10 holders included
FMR LLC, FEDERATED INVESTORS INC /PA/, WELLINGTON MANAGEMENT GROUP LLP, BAKER BROS. ADVISORS LP, GOLDMAN SACHS GROUP INC, ADAGE CAPITAL PARTNERS GP LLC, ORBIMED ADVISORS LLC, Rock Springs Capital Management LP, DEERFIELD MANAGEMENT CO, and EcoR1 Capital, LLC.
This page lists
43
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2015 vs Q3 2015 Across Filers
Q3 2015 holders
37
Q4 2015 holders
43
Holder diff
6
| Investor | Q3 2015 Shares | Q4 2015 Shares | Share Diff | Share Chg % | Q3 2015 Value $ | Q4 2015 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.